- Investopedia•18 hours ago
Akorn Inc. was slapped with a warning letter after the FDA found 6 quality-control violations at its Decatur, Illinois, drug manufacturing plant.
- GlobeNewswire•9 days ago
LAKE FOREST, Ill., Oct. 13, 2016-- Akorn, Inc., a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on Thursday, November 3, 2016 outlining the third ...
- Forbes•18 days ago
John Kapoor made his billions by letting his drug companies push legal and ethical limits. Nothing went wrong when they sold blood pressure pills, but lately one of his firms has used aggressive tactics to push one of the strongest narcotics in the world.
Akorn, Inc. (AKRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||26.33 x 400|
|Ask||33.26 x 300|
|Day's Range||26.26 - 27.26|
|52wk Range||17.57 - 39.46|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||18.02|
|Avg Vol (3m)||1,180,453|
|Dividend & Yield||0.00 (0.00%)|